Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has well-established weight-loss benefits. Cagrilintide, a long-acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit US$ 25.76 Min. order: 1 piece ★★★★★ 4.5 (35 reviews) Sold : Login>>
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI US$ 25.11 Min. order: 1 piece ★★★★★ 4.4 (36 reviews) Sold : Login>>
FOXO4-DRI improves spermatogenesis in aged mice through reducing senescence-associated secretory phenotype secretion from Leydig cells US$ 21.94 Min. order: 1 piece ★★★★★ 4.1 (158 reviews) Sold : Login>>